Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Engineered Dendritic Cell Vaccines for Multiple Myeloma

NCT06435910

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Not yet recruiting

Safety and Efficacy of Elranatamab Plus Isatuximab, Bortezomib, and Lenalidomide in Ultra-High-Risk Multiple Myeloma

NCT07789522

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Universal 4SCAR7U Targeting CD7-positive Malignancies

NCT05995028

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Not yet recruiting

CAR-T Immunotherapy Targeting CD19- ALL

NCT04016129

Conditions: B-cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Not yet recruiting

CM336-SOC for Dynamically High-Risk Multiple Myeloma Study

NCT07648459

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

NCT04033302

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Not yet recruiting

Multi-CAR-T Cells Targeting B Cell Lymphomas

NCT04429438

Conditions: B Cell Lymphoma (BCL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Shenzhen Geno-Immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Not yet recruiting

Topical JAK-Inhibition of Early-Stage CTCL

NCT07781449

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

NCT07508995

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Not yet recruiting

A Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).

NCT07784101

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

Peking University Third Hospital Beijing, Beijing Municipality, China

Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

Xinqiao Hospital of Army Medical University Chongqing, Chongqing Municipality, China

View all 24 locations

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions